145 related articles for article (PubMed ID: 20442458)
1. Management of late-presenting patients with HIV infection.
Rockstroh JK; Gatell J; Landman R; Antinori A
Antivir Ther; 2010; 15 Suppl 1():25-30. PubMed ID: 20442458
[TBL] [Abstract][Full Text] [Related]
2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
3. [Clinical management of acute and chronic human immunodeficiency virus infection before starting antiretroviral treatment].
Miró JM; Manzardo C; Zamora L; Pumarola T; Herreras Z; Gallart T; Gatell JM
Enferm Infecc Microbiol Clin; 2011 Dec; 29(10):759-72. PubMed ID: 22078726
[TBL] [Abstract][Full Text] [Related]
4. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
5. Genotypic resistance tests for the clinical management of patients with primary HIV infection.
Narciso P; Lazzarin A
Scand J Infect Dis Suppl; 2003; 106():66-70. PubMed ID: 15000588
[TBL] [Abstract][Full Text] [Related]
6. HIV resistance testing: a new clinical tool.
Jorden VS; Paul SM
N J Med; 2000 Oct; 97(10):33-8. PubMed ID: 11064565
[TBL] [Abstract][Full Text] [Related]
7. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
Gupta SB; Pujari SN; Joshi SR; Patel AK;
J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
[TBL] [Abstract][Full Text] [Related]
8. Managing antiretroviral therapy: changing regimens, resistance testing, and the risks from structured treatment interruptions.
Eron JJ
J Infect Dis; 2008 May; 197 Suppl 3():S261-71. PubMed ID: 18447612
[TBL] [Abstract][Full Text] [Related]
9. Persistence of HIV-1 drug resistance mutations and emergence during antiretroviral treatment interruption: considerations from a clinical case.
Torti C; Moretti F; Uccelli MC; Tirelli V; Quiros-Roldan E; Gargiulo F; Carosi G
Med Sci Monit; 2003 Apr; 9(4):CS16-9. PubMed ID: 12709675
[TBL] [Abstract][Full Text] [Related]
10. Strategies to optimize HIV treatment outcomes in resource-limited settings.
Nakanjako D; Colebunders R; Coutinho AG; Kamya MR
AIDS Rev; 2009; 11(4):179-89. PubMed ID: 19940945
[TBL] [Abstract][Full Text] [Related]
11. HIV infection and AIDS.
Lloyd A
P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
[TBL] [Abstract][Full Text] [Related]
12. [Clinically significant drug interactions in HIV-infected patients].
Weisser M; Battegay M
Ther Umsch; 1998 May; 55(5):310-22. PubMed ID: 9643129
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy.
Novak RM; Chen L; MacArthur RD; Baxter JD; Huppler Hullsiek K; Peng G; Xiang Y; Henely C; Schmetter B; Uy J; van den Berg-Wolf M; Kozal M;
Clin Infect Dis; 2005 Feb; 40(3):468-74. PubMed ID: 15668873
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for use of antiretroviral therapy for HIV infected individuals in India (ART guidelines 2008).
Pujari S; Patel A; Joshi SR; Gangakhedkar R; Kumarasamy N; Gupta SB;
J Assoc Physicians India; 2008 May; 56():339-48, 353-71. PubMed ID: 18700643
[No Abstract] [Full Text] [Related]
15. Genotypic resistance tests in the management of the HIV-infected patient at virological failure.
Aceti A; Carosi G
Scand J Infect Dis Suppl; 2003; 106():61-6. PubMed ID: 15000587
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of chronic hepatitis B].
Mauss S
MMW Fortschr Med; 2008 Apr; 150 Spec No 1():48-51. PubMed ID: 19031564
[No Abstract] [Full Text] [Related]
17. Antiretroviral regimens for treatment-experienced patients with HIV-1 infection.
Lagnese M; Daar ES
Expert Opin Pharmacother; 2008 Apr; 9(5):687-700. PubMed ID: 18345948
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.
Hirsch MS; Günthard HF; Schapiro JM; Brun-Vézinet F; Clotet B; Hammer SM; Johnson VA; Kuritzkes DR; Mellors JW; Pillay D; Yeni PG; Jacobsen DM; Richman DD
Clin Infect Dis; 2008 Jul; 47(2):266-85. PubMed ID: 18549313
[TBL] [Abstract][Full Text] [Related]
19. [Management of urological patients with HIV infection].
Zabirov KI; Maksimov VA; Borisik VI; Iarovoĭ SK; Prokhorov AV; Balykov IS
Urologiia; 2010; (2):6-10. PubMed ID: 20967988
[TBL] [Abstract][Full Text] [Related]
20. Late presentation of HIV-infected individuals.
Battegay M; Fluckiger U; Hirschel B; Furrer H
Antivir Ther; 2007; 12(6):841-51. PubMed ID: 17926639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
